File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Patient-derived induced pluripotent stem cells differentiated cardiomyocytes as platform for disease modeling for X-linked dilated cardiomyopathy

TitlePatient-derived induced pluripotent stem cells differentiated cardiomyocytes as platform for disease modeling for X-linked dilated cardiomyopathy
Authors
Issue Date2020
PublisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/nmd
Citation
The 25th International Congress of the World Muscle Society, Virtual Congress, 28 September – 2 October 2020. In Neuromuscular Disorder, 2020, v. 30 n. Suppl. 1, p. S106 How to Cite?
AbstractX-linked dilated cardiomyopathy (XLDCM) is a serious condition caused by abnormalities in the DMD gene (dystrophin gene). The affected patients did not have major skeletal weakness but presented with early signs of heart failure, and deteriorated quickly despite medical treatment resulting in early death. Currently there is no curative treatment and heart transplantation is often required. We study the pathomechanism of the DMD-associated XLDCM with mutation in the first exon-intron boundary, through examination of dystrophin isoforms expression and the functional characterization of the manifested cardiomyocytes generated from patient-derived induced pluripotent stem cells (IPSCs) compared to normal control. We generated integration-free IPSCs derived from the peripheral blood mononuclear cells (PBMCs) of our XLDCM patient with DMD c.31+1G>A intron 1 splice site mutation. A healthy donor was recruited as normal control. Pluripotency of iPSC clones was confirmed by immunofluorescent staining, RT-PCR and teratoma formation. Patient and control IPSC cell lines were maintained and differentiated into cardiomyocytes (CM) with in-house protocol. The CMs generated were pathologically and functionally characterized. The patient-derived iPSCs pluripotency was confirmed. Cardiomyocytes differentiated from the iPSCs of the patient and the normal control expressed cardiac-specific markers and displayed electrically induced calcium transients. Decreased expression of dystrophin isoforms is associated with high osmotic fragility to hypotonic stress and abnormal calcium handling in the patient-derived iPSCs differentiated CM, as compared with that from normal control. This XLDCM patient-derived IPSCs model serves as an effective disease platform to study disease mechanisms.
DescriptionPoster session 3: DMD - Animal models & Preclinical treatment - no. P.204
Persistent Identifierhttp://hdl.handle.net/10722/305564
ISSN
2023 Impact Factor: 2.7
2023 SCImago Journal Rankings: 0.824
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorZhu, S-
dc.contributor.authorDeng, MR-
dc.contributor.authorLaw, HY-
dc.contributor.authorPoon, E-
dc.contributor.authorLo, J-
dc.contributor.authorLiang, R-
dc.contributor.authorKwong, AKY-
dc.contributor.authorNg, K-
dc.contributor.authorTse, H-
dc.contributor.authorChan, GCF-
dc.contributor.authorChan, HSS-
dc.date.accessioned2021-10-20T10:11:11Z-
dc.date.available2021-10-20T10:11:11Z-
dc.date.issued2020-
dc.identifier.citationThe 25th International Congress of the World Muscle Society, Virtual Congress, 28 September – 2 October 2020. In Neuromuscular Disorder, 2020, v. 30 n. Suppl. 1, p. S106-
dc.identifier.issn0960-8966-
dc.identifier.urihttp://hdl.handle.net/10722/305564-
dc.descriptionPoster session 3: DMD - Animal models & Preclinical treatment - no. P.204-
dc.description.abstractX-linked dilated cardiomyopathy (XLDCM) is a serious condition caused by abnormalities in the DMD gene (dystrophin gene). The affected patients did not have major skeletal weakness but presented with early signs of heart failure, and deteriorated quickly despite medical treatment resulting in early death. Currently there is no curative treatment and heart transplantation is often required. We study the pathomechanism of the DMD-associated XLDCM with mutation in the first exon-intron boundary, through examination of dystrophin isoforms expression and the functional characterization of the manifested cardiomyocytes generated from patient-derived induced pluripotent stem cells (IPSCs) compared to normal control. We generated integration-free IPSCs derived from the peripheral blood mononuclear cells (PBMCs) of our XLDCM patient with DMD c.31+1G>A intron 1 splice site mutation. A healthy donor was recruited as normal control. Pluripotency of iPSC clones was confirmed by immunofluorescent staining, RT-PCR and teratoma formation. Patient and control IPSC cell lines were maintained and differentiated into cardiomyocytes (CM) with in-house protocol. The CMs generated were pathologically and functionally characterized. The patient-derived iPSCs pluripotency was confirmed. Cardiomyocytes differentiated from the iPSCs of the patient and the normal control expressed cardiac-specific markers and displayed electrically induced calcium transients. Decreased expression of dystrophin isoforms is associated with high osmotic fragility to hypotonic stress and abnormal calcium handling in the patient-derived iPSCs differentiated CM, as compared with that from normal control. This XLDCM patient-derived IPSCs model serves as an effective disease platform to study disease mechanisms.-
dc.languageeng-
dc.publisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/nmd-
dc.relation.ispartofNeuromuscular Disorders-
dc.relation.ispartofThe 25th International Congress of the World Muscle Society 2020-
dc.titlePatient-derived induced pluripotent stem cells differentiated cardiomyocytes as platform for disease modeling for X-linked dilated cardiomyopathy-
dc.typeConference_Paper-
dc.identifier.emailLaw, HY: lawanna@hkucc.hku.hk-
dc.identifier.emailKwong, AKY: kkyanna@hku.hk-
dc.identifier.emailChan, GCF: gcfchan@hku.hk-
dc.identifier.emailChan, HSS: sophehs@hku.hk-
dc.identifier.authorityChan, GCF=rp00431-
dc.identifier.authorityChan, HSS=rp02210-
dc.description.natureabstract-
dc.identifier.doi10.1016/j.nmd.2020.08.205-
dc.identifier.hkuros328090-
dc.identifier.volume30-
dc.identifier.issueSuppl. 1-
dc.identifier.spageS106-
dc.identifier.epageS106-
dc.identifier.isiWOS:000579727800200-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats